Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Longitudinal melanonychia and hydroxyurea]

C Pirard1, J L Michaux, A Bourlond

  • 1Service de Dermatologie, Cliniques universitaires Saint-Luc, Bruxelles-Belgique.

Annales De Dermatologie Et De Venereologie
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Hydroxyurea treatment for chronic myeloid leukaemia can cause a rare side effect: intense longitudinal melanonychia, affecting up to half of a patient's nails. This finding highlights a potential dermatological complication of this common leukemia therapy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Ophtalmological adverse events related to immune checkpoint inhibitors].

Revue medicale de Liege·2022
Same author

[Ten years ahead in infectious diseases : AIDS/ HIV towards stopping transmission].

Revue medicale de Liege·2020
Same author

[Therapeutic progress in the control of uncomplicated Plasmodium falciparum malaria].

Revue medicale de Liege·2020
Same author

[Association between exposure to persistent organic pollutants during pregnancy and thyroid function during childhood : a pilot longitudinal study and literature review].

Revue medicale de Liege·2020
Same author

Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

Leukemia & lymphoma·2016
Same author

Hypothyroidism Associated with Myeloid Neoplasia.

Acta clinica Belgica·2016
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Dermatology
  • Hematology
  • Pharmacology

Background:

  • Chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm.
  • Hydroxyurea is a common chemotherapeutic agent used in CML treatment.
  • Drug-induced nail changes can occur, but severe melanonychia is uncommon.